Biography
Pier Paolo Piccaluga has done MD with honors from Bologna University (1997). He did Specialty in Hematology with honors (2001), PhD in Clinical and Experimental Hematology at Bologna University (2005), Specialty in Pathology with honors at Siena University (2014) and Post-doctoral fellowship at Columbia University, New York (USA). He is a Visiting fellow at Columbia University (USA, 2008) and Kiel University (Germany, 2009), Lecturer in Pathology at Bologna University: 2006-2012. Currently he is appointed as Associate Professor at the Department of Experimental, Diagnostic, and Specialty Medicine, Bologna University Medical School, Italy.
Research Interest
Pathology,Cancer biology,Metabolomics
Biography
Dr. Mojtaba Mafi is a physician/Medical Doctor. He received M.D. degree from Tehran university school of Medicine with honors and passed successfully many postgraduate Medical education programs approved by Medical sciences university and successfully passed more than 10 programs with certificates and membership in Iranian Association Gastroenterology and Hepatology having honor of working as associate of Iran Hepatitis Network and Gastroenterology and Hepatology research center, Middle East Liver Diseases Center (MELD). He worked clinically in Neurosurgery ward Shariati hospital for Thesis on Brain tumors and Meningioma for 6 years till 2008. He is Now active in clinical setting and scientific field and currently works on fatty liver and related metabolic disorders (Diabetes-Dyslipidemia-Genetics) at Iran Hepatitis Network. He is organizing scientific committee member of International conference on obesity and diet imbalance in Indonesia and speaker of the conference on obesity and chronic diseases at Dubai October 2018. Dr. Mojtaba Mafi has invited a speaker in Global and European neurosurgery and neurology conferences in Rome, Italy, and London. He is Reviewer of international hepatology journals and Invited editorial board member of psychology and neuroscience journal. Dr. Mafi is speaker of 4th International conference on Diabetes in Dubai 2018. He is speaker of the world congress on neuronal synchronization London 2018 and speaker of International neuro-oncology conference in Dubai September 2018. He is honorable speaker of 2nd International conference on Cardiology, Paris and 26th International Neurology conference in Japan and Invited speaker of 2nd International Gastroenterology and hepatology conference in Bangkok, November 2018. Dr. Mojtaba Mafi is Board member of International Journal of psychology and neuroscience. Dr. Mafi is Speaker of the 5th annual conference on stroke and neuro disorders, Turkey, November 2018. He has invited Organizing Committee Member in 3rd International Conference on Alzheimer's Disease and Dementia held in London, 2019 and speaker of 12th International Conference on Osteoporosis, Arthritis and Musculoskeletal disorders in London 2019.
Research Interest
metabolic disorders(Diabetes-Dyslipidemia-Genetics),Neurosurgery specialised in Brain tumors and meningioma
Biography
Dr. Subrahmanyam Vangala is currently Founder and Chief Executive Officer at ReaGene Biosciences Private Limited (Bangalore, India). He is an experienced pharma scientist and executive with more than two decades of leadership experience with increasing responsibilities, at global pharma in USA (Wyeth, JNJ, Purdue Pharma and the Shire) and Contract Research Organizations in India (Sai Life and Advinus). He received his Ph.D. Degree in Biochemical Mechanisms of Chemical Carcinogenesis from the Department of Biochemistry, Memorial University of Newfoundland, Canada. He conducted his postdoctoral research in Molecular Toxicology department at University of Colorado at Boulder and continued as a Specialist Scientist (Research Assistant Professor) in Molecular Toxicology at School of Public Health, University of California, Berkeley. Extensive experience in leading DMPK/ADME and Toxicology departments including Clinical Pharmacology, Bioanalytical and Electronic Documentation groups. Managed up to 75 personnel (Research Scientist to Senior Director levels). Built infrastructures from scratch. Supported pharmacokinetics, toxicokinetics, drug metabolism, drug-drug interactions, in-silico modeling, allometric scaling and first-in-human dosing projections, mechanistic pharmacology/toxicology, pharmacogenomics/ toxicogenomics/metabolomics, genetic toxicology, high-resolution mass spectrometry for metabolite identification, pre-formulation development, 3D model development. Prepared short term and long term business plans, budgets, proactively identified road bumps and collaborated extensively with other departments to prepare and execute remedial action plans. He brings with him, unique insights into translational research. He is on the scientific advisory board of Bioagile therapeutics and on the editorial board of journals related to toxicology and analytical research. He has 50 plus peers reviewed publications in peer-reviewed journals including invited book chapters. He has chaired several international symposia in predictive toxicology, idiosyncratic drug toxicity, and DMPK. Served as an editorial board member for international journals. Currently serving as a chief scientific advisor for Bioagile Therapeutics, Trana Labs and Care hospitals. Selected to the expert committee panel for ICMR (Indian Council of Medical Research) on non-animal technologies and prepared a white paper along with other core expert team members. His Current research interests include developing in vitro 3D human models of translational pharmacology and toxicology research for improved clinical translation and use as alternatives to animals in research. Applications of OMICS (Genomics and Metabolomics) with human 3D models to support precision medicine concepts.
Research Interest
His Current research interests include developing in vitro 3D human models of translational pharmacology and toxicology research for improved clinical translation and use as alternatives to animals in research. Applications of OMICS (Genomics and Metabolomics) with human 3D models to support precision medicine concepts.